ungeremine has been researched along with Glioma in 1 studies
*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Fu, Y; Gong, T; Song, X; Yang, L; Zhang, Z | 1 |
1 other study(ies) available for ungeremine and Glioma
| Article | Year |
|---|---|
nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Hormonal; Cell Proliferation; Central Nervous System Neoplasms; Drug Delivery Systems; Glioma; Indolizines; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Octreotide; Oligopeptides; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 2017 |